| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| OEM(元) | 72,903,192.37 | 164,863,757.26 | 73,533,733.49 | 210,466,252.84 |
| 电生理(元) | 245,601,375.51 | 440,030,814.80 | 223,317,589.50 | 367,530,175.59 |
| 非血管介入类(元) | 22,838,199.44 | 38,521,826.76 | 16,350,926.25 | 16,388,806.02 |
| 冠脉通路类(元) | 654,284,608.47 | 1,054,493,577.41 | 503,229,514.24 | 791,095,551.12 |
| 外周介入类(元) | 212,577,731.99 | 351,275,868.48 | 175,211,576.07 | 256,242,748.21 |
| 营业成本(元) | ||||
| OEM(元) | 28,264,319.70 | 60,964,630.90 | 28,561,255.07 | 79,104,079.41 |
| 电生理(元) | 61,087,007.91 | 115,479,725.81 | 57,967,836.68 | 93,914,223.02 |
| 非血管介入类(元) | 8,746,166.70 | 15,450,073.87 | 7,110,507.43 | 8,197,305.25 |
| 冠脉通路类(元) | 170,962,959.57 | 282,446,145.79 | 129,833,050.63 | 222,503,896.44 |
| 外周介入类(元) | 48,581,600.00 | 84,786,242.50 | 42,157,367.56 | 64,696,324.05 |
| 毛利(元) | ||||
| OEM(元) | 44,638,872.67 | 103,899,126.36 | 44,972,478.42 | 131,362,173.43 |
| 电生理(元) | 184,514,367.60 | 324,551,088.99 | 165,349,752.82 | 273,615,952.57 |
| 非血管介入类(元) | 14,092,032.74 | 23,071,752.89 | 9,240,418.82 | 8,191,500.77 |
| 冠脉通路类(元) | 483,321,648.90 | 772,047,431.62 | 373,396,463.61 | 568,591,654.68 |
| 外周介入类(元) | 163,996,131.99 | 266,489,625.98 | 133,054,208.51 | 191,546,424.16 |
| 毛利率(%) | ||||
| OEM(%) | 61.23 | 63.02 | 61.16 | 62.41 |
| 电生理(%) | 75.13 | 73.76 | 74.04 | 74.45 |
| 非血管介入类(%) | 61.70 | 59.89 | 56.51 | 49.98 |
| 冠脉通路类(%) | 73.87 | 73.21 | 74.20 | 71.87 |
| 外周介入类(%) | 77.15 | 75.86 | 75.94 | 74.75 |
| 收入构成(%) | ||||
| OEM(%) | 6.03 | 8.05 | 7.42 | 12.82 |
| 电生理(%) | 20.33 | 21.47 | 22.52 | 22.39 |
| 非血管介入类(%) | 1.89 | 1.88 | 1.65 | 1.00 |
| 冠脉通路类(%) | 54.15 | 51.46 | 50.75 | 48.19 |
| 外周介入类(%) | 17.59 | 17.14 | 17.67 | 15.61 |
| 毛利构成(%) | ||||
| OEM(%) | 5.01 | 6.97 | 6.19 | 11.20 |
| 电生理(%) | 20.72 | 21.78 | 22.78 | 23.32 |
| 非血管介入类(%) | 1.58 | 1.55 | 1.27 | 0.70 |
| 冠脉通路类(%) | 54.27 | 51.81 | 51.43 | 48.46 |
| 外周介入类(%) | 18.41 | 17.88 | 18.33 | 16.33 |